ArticleJournal of theoretical biology2023
Exploring the role of superspreading events in SARS-CoV-2 outbreaks.
Article in Journal of theoretical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Recombinant RBD-based subunit vaccines incorporating high-frequency mutation sites elicit cross-immunity and robust protection against SARS-CoV-2.Frontiers in microbiology · 2026Article
- RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2.Journal of nanobiotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The novel coronavirus SARS-CoV-2 emerged in 2019 and subsequently spread throughout the world, causing over 600 million cases and 6 million deaths as of September 7th, 2022. Superspreading events (SSEs), defined here as public or social events that result in multiple infections over a short time span, have contributed to SARS-CoV-2 spread. In this work, we compare the dynamics of SSE-dominated SARS-CoV-2 outbreaks, defined here as outbreaks with relatively higher SSE rates, to the dynamics of non-SSE-dominated SARS-CoV-2 outbreaks. To accomplish this, we derive a continuous-time Markov chain (CTMC) SARS-CoV-2 model from an ordinary differential equation (ODE) SARS-CoV-2 model and incorporate SSEs using an events-based framework. We simulate our model under multiple scenarios using Gillespie's direct algorithm. The first scenario excludes hospitalization and quarantine; the second scenario includes hospitalization, quarantine, premature hospital discharge, and quarantine violation; and the third scenario includes hospitalization and quarantine but excludes premature hospital discharge and quarantine violation. We also vary quarantine violation rates. Results indicate that, with either no control or imperfect control, SSE-dominated outbreaks are more variable but less severe than non-SSE-dominated outbreaks, though the most severe SSE-dominated outbreaks are more severe than the most severe non-SSE-dominated outbreaks. We measure severity by the time it takes for 50 active infections to be achieved; more severe outbreaks do so more quickly. SSE-dominated outbreaks are also more sensitive to control measures, with premature hospital discharge and quarantine violation substantially reducing control measure effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.